Bioventus Inc (BVS)
14.16
+0.58
(+4.27%)
USD |
NASDAQ |
Nov 04, 13:09
Bioventus Total Assets (Quarterly): 792.17M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 792.17M |
| March 31, 2024 | 794.24M |
| December 31, 2023 | 810.91M |
| September 30, 2023 | 811.10M |
| June 30, 2023 | 836.96M |
| March 31, 2023 | 887.40M |
| December 31, 2022 | 1.373B |
| September 30, 2022 | 1.398B |
| June 30, 2022 | 1.209B |
| Date | Value |
|---|---|
| March 31, 2022 | 1.197B |
| December 31, 2021 | 1.226B |
| September 30, 2021 | 654.79M |
| June 30, 2021 | 646.64M |
| March 31, 2021 | 643.08M |
| December 31, 2020 | 494.47M |
| September 30, 2020 | 479.28M |
| December 31, 2019 | 472.41M |
| March 31, 2016 | 486.26M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
472.41M
Minimum
Dec 2019
1.398B
Maximum
Sep 2022
866.23M
Average
810.91M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp | 37.11B |
| Insulet Corp | 2.882B |
| Perspective Therapeutics Inc | 385.92M |
| Xtant Medical Holdings Inc | 95.58M |
| Catheter Precision Inc | 26.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 603.11M |
| Shareholders Equity (Quarterly) | 150.94M |
| Debt to Equity Ratio | 2.539 |
| Current Ratio | 1.334 |
| Net Debt Paydown Yield | 3.33% |